IRCT20210609051526N1尚未招募3 期
Efficiency of linagliptin on insulin dosage in type 2 diabetes patients with sever renal failure (randomized clinical trial)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Type 2 diabetes
- •Severe renal failure (GFR below 30)
- •Age 80 - 18 years
- •HbA1C between 7 and 10
排除标准
- •Inability to follow the patient
- •Discontinue insulin or linagliptin
研究者
相似试验
已完成
不适用
Efficacy of linagliptin on glycemic control in diabetic patients on hemodialysis [Diamond study-1]Diabetic patients on hemodialysisJPRN-UMIN000007635Diamond study group80
已完成
不适用
Safety and efficacy of linagliptin for glycemic control in non-critically ill hospitalized patients with type 2 diabetesJPRN-UMIN000034778Ichinomiyanishi Hospital60
招募中
3 期
Effect of Linagliptin on Diabetic patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210812052156N1Gonabad University of Medical Sciences70
进行中（未招募）
不适用
Effect of Linagliptin in comparison with Glimepiride as add on to Metformin on the metabolism of diabetic patients after a meal.Diabetes mellitus type 2 on metformin therapyMedDRA version: 14.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000179-17-DEikfe GmbH
已完成
3 期
Linagliptin Add-on to Insulin Background TherapyDiabetes Mellitus, Type 2NCT02897349Boehringer Ingelheim206